IPAR vs. PBH, EPC, HLF, USNA, NUS, NATR, MED, REV, VERU, and EL
Should you be buying Inter Parfums stock or one of its competitors? The main competitors of Inter Parfums include Prestige Consumer Healthcare (PBH), Edgewell Personal Care (EPC), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Revlon (REV), Veru (VERU), and Estée Lauder Companies (EL).
Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment.
Prestige Consumer Healthcare presently has a consensus target price of $91.25, suggesting a potential upside of 42.00%. Inter Parfums has a consensus target price of $178.67, suggesting a potential upside of 55.82%. Given Prestige Consumer Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.
In the previous week, Prestige Consumer Healthcare had 10 more articles in the media than Inter Parfums. MarketBeat recorded 15 mentions for Prestige Consumer Healthcare and 5 mentions for Inter Parfums. Prestige Consumer Healthcare's average media sentiment score of 0.95 beat Inter Parfums' score of 0.27 indicating that Inter Parfums is being referred to more favorably in the news media.
Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.
Prestige Consumer Healthcare has a net margin of 18.60% compared to Prestige Consumer Healthcare's net margin of 10.50%. Prestige Consumer Healthcare's return on equity of 15.85% beat Inter Parfums' return on equity.
Prestige Consumer Healthcare has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.
100.0% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Inter Parfums shares are held by institutional investors. 1.6% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 43.9% of Inter Parfums shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Prestige Consumer Healthcare received 38 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.70% of users gave Prestige Consumer Healthcare an outperform vote while only 64.22% of users gave Inter Parfums an outperform vote.
Summary
Inter Parfums beats Prestige Consumer Healthcare on 11 of the 18 factors compared between the two stocks.
Get Inter Parfums News Delivered to You Automatically
Sign up to receive the latest news and ratings for IPAR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IPAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inter Parfums Competitors List
Related Companies and Tools
